Association of interleukin-10 gene promoter polymorphisms with chronic and aggressive periodontitis

Oral Diseases

Volumn 18, Issue 3, 2012, Pages 271-279

  Jaradat, S M ^a   Ababneh, K T ^b   Jaradat, S A ^c,d   Abbadi, M S ^e   Taha, A H ^f   Karasneh, J A ^b   Haddad, H I ^c,d  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

^c KING ABDULLAH UNIVERSITY HOSPITAL   (Jordan)

^d Department of Biotechnology and Genetic Engineering   (Jordan)

^e Private Dental Practice   (Jordan)

^f Private Dental Practices   (United Arab Emirates)

Author keywords

Interleukin 10; Periodontitis; Single nucleotide polymorphism

Indexed keywords

DNA; INTERLEUKIN 10;

ADULT; AGGRESSIVE PERIODONTITIS; ARTICLE; CHRONIC PERIODONTITIS; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIODONTITIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADENINE; ADOLESCENT; ADULT; AGGRESSIVE PERIODONTITIS; ALLELES; CHRONIC PERIODONTITIS; CYTOSINE; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENOTYPE; GUANINE; HUMANS; INTERLEUKIN-10; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK FACTORS;

EID: 84857799669     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2011.01872.x     Document Type: Article

References (56)

1. Agrawal S, Agrawal A, Doughty B et al (2003). Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos. J Immunol 171: 4984-4989.
2. al-Janadi M, al-Dalaan A, al-Balla S, al-Humaidi M, Raziuddin S (1996). Interleukin-10 (IL-10) secretion in systemic lupus erythematosus and rheumatoid arthritis: IL-10-dependent CD4+CD45RO+ T cell-B cell antibody synthesis. J Clin Immunol 16: 198-207.
3. Armitage GC (1999). Development of a classification system for periodontal diseases and conditions. Ann Periodontol 4: 1-6.
4. Babel N, Cherepnev G, Babel D et al (2006). Analysis of tumor necrosis factor-alpha, transforming growth factor-beta, interleukin-10, IL-6, and interferon-gamma gene polymorphisms in patients with chronic periodontitis. J Periodontol 77: 1978-1983.
5. Bazzoni F, Tamassia N, Rossato M, Cassatella MA (2010). Understanding the molecular mechanisms of the multifaceted IL-10-mediated antiinflammatory response: lessons from neutrophils. Eur J Immunol 40: 2360-2368.
6. Berglundh T, Liljenberg B, Tarkowski A, Lindhe J (2002). The presence of local and circulating autoreactive B cells in patients with advanced periodontitis. J Clin Periodontol 29: 281-286.
7. Brett PM, Zygogianni P, Griffiths GS et al (2005). Functional gene polymorphisms in aggressive and chronic periodontitis. J Dent Res 84: 1149-1153.
8. Burt BA (1994). Periodontitis and aging: reviewing recent evidence. J Am Dent Assoc 125: 273-279.
9. Couper KN, Blount DG, Riley EM (2008). IL-10: the master regulator of immunity to infection. J Immunol 180: 5771-5777.
10. Dashash M, Drucker DB, Blinkhorn AS (2006). Interleukin-10 haplotype frequencies in children with gingivitis. J Periodontol 77: 1503-1509.
11. Dillon S, Agrawal A, Van Dyke T et al (2004). A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells. J Immunol 172: 4733-4743.
12. El Kasmi KC, Holst J, Coffre M et al (2006). General nature of the STAT3-activated anti-inflammatory response. J Immunol 177: 7880-7888.
13. Eskdale J, Gallagher G, Verweij CL, Keijsers V, Westendorp RG, Huizinga TW (1998). Interleukin-10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci USA 95: 9465-9470.
14. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A (1991). IL-10 inhibits cytokine production by activated macrophages. J Immunol 147: 3815-3822.
15. Gaffen SL, Hajishengallis G (2008). A new inflammatory cytokine on the block: re thinking periodontal disease and the Th1/Th2 paradigm in the context of the Th17 cells and IL-17. J Dent Res 87: 817-828.
16. Gonzales JR, Michel J, Diete A, Herrmann JM, Bödeker RH, Meyle J (2002). Analysis of genetic polymorphisms at the interleukin-10 loci in aggressive and chronic periodontitis. J Clin Periodontol 29: 816-822.
17. Hart PH, Hunt EK, Bonder CS, Watson CJ, Finlay-Jones JJ (1996). egulation of surface and soluble TNF receptor expression on human monocytes and synovial fluid macrophages by IL-4 and IL-10. J Immunol 157: 3672-3680.
18. de Heens GL, Kikkert R, Aarden LA, van der Velden U, Loos BG (2009). Effects of smoking on the ex vivo cytokine production in periodontitis. J Periodontal Res 44: 28-34.
19. Hu KF, Huang KC, Ho YP et al (2009). Interleukin-10 (-592 C/A) and interleukin-12B (+16974 A/C) gene polymorphisms and the interleukin-10 ATA haplotype are associated with periodontitis in a Taiwanese population. J Periodontal Res 44: 378-385.
20. Jenkins JK, Malyak M, Arend WP (1994). The effects of interleukin-10 on interleukin-1 receptor antagonist and interleukin-1 beta production in human monocytes and neutrophils. Lymphokine Cytokine Res 13: 47-54.
21. Kinane DF, Hodge P, Eskdale J, Ellis R, Gallagher G (1999). Analysis of genetic polymorphisms at the interleukin-10 and tumour necrosis factor loci in early-onset periodontitis. J Periodontal Res 34: 379-386.
22. Kube D, Platzer C, Von Knethen A et al (1995). Isolation of the human interleukin 10 promoter: characterization of the promoter activity in Burkitt's lymphoma cell lines. Cytokine 7: 1-7.
23. Larsson L, Johansson P, Jansson A, Donati M, Rymo L, Berglundh T (2009). The Sp1 transcription factor binds to the G-allele of the -1087 IL-10 gene polymorphism and enhances transcriptional activation. Genes Immunol 10: 280-284.
24. Larsson L, Rymo L, Berglundh T (2010). Sp1 binds to the G allele of the-1087 polymorphism in the IL-10 promoter and promotes IL-10 mRNA transcription and protein production. Genes Immunol 11: 181-187.
25. Liu J, Song B, Bai X et al (2010). Association of genetic polymorphisms in the interleukin-10 promoter with risk of prostate cancer in Chinese. BMC Cancer 24: 456-463.
26. Llorente L, Richaud-Patin Y, Wijdenes J et al (1993). Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus. Eur Cytokine Netw 4: 421-427.
27. Llorente L, Richaud-Patin Y, Fior R et al (1994). In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjögren's syndrome, and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity and autoimmunity. Arthritis Rheum 37: 1647-1655.
28. Llorente L, Richaud-Patin Y, García-Padilla C et al (2000). Clinical and biological effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus. Arthritis Rheum 43: 1790-1800.
29. Löe H, Silness J (1963). Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 21: 533-551.
30. Maynard CL, Weaver CT (2008). Diversity in the contribution of interleukin-10 to T-cell mediated immune regulation. Immunol Rev 226: 219-233.
31. Mellati E, Arab HR, Tavakkol-Afshari J, Ebadian AR, Radvar M (2007). Analysis of -1082 IL-10 gene polymorphism in Iranian patients with generalized aggressive periodontitis. Med Sci Monit 13: CR510-CR514.
32. Mok CC, Lanchbury JS, Chan DW, Lau CS (1998). Interleukin-10 promoter polymorphisms in southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum 41: 1090-1095.
33. Mongan AE, Ramdahin S, Warrington RJ (1997). Interleukin-10 response abnormalities in systemic lupus erythematosus. Scand J Immunol 46: 406-412.
34. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A (2001). Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19: 683-765.
35. O'Garra A, Barrat FJ, Castro AG, Vicari A, Hawrylowicz C (2010). Strategies for use of IL-10 or its antagonists in human disease. Immunol Rev 223: 114-131.
36. Ouyang W, Rutz S, Crellin NK, Valdez PA, Hymowitz SG (2011). Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu Rev Immunol 29: 71-109.
37. Park-Min KH, Ji JD, Antoniv T, Reid AC et al (2009). IL-10 suppresses calcium-mediated costimulation of receptor activator NF-kappa B signaling during human osteoclast differentiation by inhibiting TREM-2 expression. J Immunol 183: 2444-2455.
38. Paul G, Khare V, Gasche C (2011). Inflamed gut mucosa: downstream of interleukin-10. Eur J Clin Invest, doi:
39. Perrey C, Pravica V, Sinnott PJ, Hutchinson IV (1998). Genotyping for polymorphisms in interferon-γ, interleukin-10, transforming growth factor-β1 and tumour necrosis factor-α genes: a technical report. Transpl Immunol 6: 193-197.
40. Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y, Fisher PB (2004). Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 22: 929-979.
41. Rees LE, Wood NA, Gillespie KM, Lai KN, Gaston K, Mathieson PW (2002). The interleukin-10-1082G/A polymorphism: allele frequency in different populations and functional significance. Cell Mol Life Sci 59: 560-569.
42. Reichert S, Machulla HK, Klapproth J et al (2008). The interleukin-10 promoter haplotype ATA is a putative risk factor for aggressive periodontitis. J Periodont Res 43: 40-47.
43. Risch NJ (2000). Searching for genetic determinants in the new millennium. Nature 15: 847-856.
44. Sabat R, Grütz G, Warszawska K et al (2010). Biology of interleukin-10. Cytokine Growth Factor Rev 21: 331-344.
45. Sasaki H, Okamatsu Y, Kawai T, Kent R, Taubman M, Stashenko P (2004). The interleukin-10 knockout mouse is highly susceptible to Porphyromonas gingivalis-induced alveolar bone loss. J Periodontal Res 39: 432-441.
46. Scarel-Caminaga RM, Trevilatto PC, Souza AP, Brito RB, Camargo LE, Line SR (2004). Interleukin 10 gene promoter polymorphisms are associated with chronic periodontitis. J Clin Periodontol 31: 443-448.
47. Silness J, Löe H (1964). Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 22: 121-135.
48. Slots J (1999). Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in periodontal disease: introduction. Periodontology 2000(20): 7-13.
49. Sumer AP, Kara N, Keles GC, Gunes S, Koprulu H, Bagci H (2007). Association of interleukin-10 gene polymorphisms with severe generalized chronic periodontitis. J Periodontol 78: 493-497.
50. Temple SE, Lim E, Cheong KY et al (2003). Alleles carried at positions -819 and -592 of the IL10 promoter affect transcription following stimulation of peripheral blood cells with Streptococcus pneumoniae. Immunogenetics 55: 629-632.
51. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV (1997). An investigation of polymorphism in the interleukin 10 gene promoter. Eur J Immunogenet 24: 1-8.
52. Warlé MC, Farhan A, Metselaar HJ et al (2003). Are cytokine gene polymorphisms related to in vitro cytokine production profiles? Liver Transpl 9: 170-181.
53. Williams L, Bradley L, Smith A, Foxwell B (2004). Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages. J Immunol 172: 567-576.
54. Yamazaki K, Tabeta K, Nakajima T et al (2001). Interleukin-10 gene promoter polymorphism in Japanese patients with adult and early onset periodontitis. J Clin Periodontol 28: 828-832.
55. Yao JG, Gao LB, Liu YG, Li J, Pang GF (2008). Genetic variation in interleukin-10 gene and risk of oral cancer. Clin Chim Acta 388: 84-88.
56. Ye S, Dhillon S, Ke X, Collins AR, Day IN (2001). An efficient procedure for genotyping single nucleotide polymorphisms. Nucleic Acids Res 29: e88.